Replies to post #327611 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Don't disagree that all seems conceivable. We just won't get to market for any of those diseases without completed trials leading to approval.

Perhaps at some point after a few approvals blarcamesine can get a label update that says go ahead try it on any CNS disease and ingrown toe nails.